Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Istituto Oncologico Veneto IRCCS
Condition: Endocrine Sensitive HER2+/HR+ Breast Cancer
NCT02411344
Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.